Pharmacovigilance Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Pharmacovigilance Companies and It is Segmented by Clinical Trial Phase (Preclinical, Phase I, Phase II, Phase III, and Phase IV), Service Provider (In-House and Contract Outsourcing), Type of Reporting (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, and EHR Mining), End User (Hospitals, Pharmaceutical Companies, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Size and Value (in USD Billion) for the Above Segments.

Pharmacovigilance Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Pharmacovigilance Industry Overview

The pharmacovigilance market is moderately competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market. The key participants are involved in continuous product development, collaborations, partnerships, and alliances to augment market penetration. Some of the key market players in this market include Accenture, IBM Corporation, Wipro, Cognizant, and Capgemini, among others.

Pharmacovigilance Market Leaders

  1. Cognizant

  2. Capgemini

  3. Accenture

  4. Wipro Limited

  5. IBM

  6. *Disclaimer: Major Players sorted in no particular order
Pharmacovigilance Market  Concentration